# Trade Mark Journal No.2025/042 17 October 2025

## WO0000001878982 (5,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:14 August 2025
Date of designation in the UK: 14 August 2025

International priority date claimed: 14 March 2025 (European Union Intellectual Property Office (EUIPO)) (019156932)

Class 5
  Diagnostic biomarker reagents for medical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; diagnostic agents for medical use; diagnostic reagents for medical use; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations for medical purposes, diagnostic substances and diagnostic materials; medical diagnostic test strips; diagnostic preparations for medical purposes.
Class 42
  Design and development of the following goods: blood-based biomarkers for the identification, quantification and analysis of disease activity; design and development of the following goods: diagnostic biomarker reagents for medical purposes, for pharmaceutical purposes and for scientific purposes; design and development of the following goods: biochemical and pharmaceutical assays and medical samples; design and development of the following goods: biomarkers for individual use or combined for the tracking of tissue formation, development or tissue degradation; pharmaceutical and scientific research relating to the following fields: biomarkers and the detection of biomarkers; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to the following fields: clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data in connection with the following fields: biomarkers; development of the following goods: diagnostic preparations for medical purposes, diagnostic equipment and diagnostic tests; clinical testing services; diagnostic testing services; testing services relating to the following fields: tracking and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratories; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis; information, advice and assistance relating to the aforementioned services.

Nordic Bioscience A/S

Representative: CHAS. HUDE A/S, Langebrogade 3B, DK-1411 København K, DENMARK